[Venous Vascular Malformations and Their Treatment with Ethibloc]

Overview

Journal J Mal Vasc

Specialty Cardiology & Vascular Diseases

Date 1992 Jan 1

PMID 1588234

Citations 5

Authors

D Herbreteau

M C Riche

O Enjolras

F Lemarchand

C Laurian

M D Brette

J J Merland

Affiliations

Soon will be listed here.

Abstract

The use of Ethibloc must be contemplated as a first-intention treatment for venous malformations of the face. This sclerosing agent has transformed the functional, esthetic and psychological prognosis for these vascular malformations.

Citing Articles

A Rare Case of Subclavicular Cystic Lymphangioma in Adults Adhering to Axillary Vessels.

Daly H Cureus. 2023; 15(10):e47341.

PMID: 38021546 PMC: 10657233. DOI: 10.7759/cureus.47341.

Cystic lymphangioma of the upper limb: Clinical case and literature review.

Diarra D, Mekouar Y, Salihou A, Traore B, Laoudihy D, Chbani K BJR Case Rep. 2022; 8(5):20210206.

PMID: 36211611 PMC: 9518730. DOI: 10.1259/bjrcr.20210206.

[Orthopedic treatment of a pathological fracture of the femur on venous malformation: about a case].

Guelzim S, Lamrani O, Kharmaz M, Lahlou A, Elouadghiri M, El Bardouni A Pan Afr Med J. 2015; 22:3.

PMID: 26600903 PMC: 4643158. DOI: 10.11604/pamj.2015.22.3.7765.

Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia.

Orlando J, Caldas J, Campos H, Nishinari K, Wolosker N Clinics (Sao Paulo). 2010; 65(9):837-40.

PMID: 21049209 PMC: 2954733. DOI: 10.1590/s1807-59322010000900004.

A new sclerosing agent in the treatment of venous malformations. Study on 23 cases.

Sannier K, Dompmartin A, Theron J, Labbe D, Barrellier M, Leroyer R Interv Neuroradiol. 2010; 10(2):113-27.

PMID: 20587223 PMC: 3464441. DOI: 10.1177/159101990401000203.